NIH-funded research P01 program project

Sex, leptin, and endothelial energy in Type 1 Diabetes

Official title: Sex and Leptin control of endothelial cell glycolysis and redox balance in Type 1 Diabetes

Funded at Augusta University · NIH-11337458 · Data updated 2026-11-12

This grant studies how the energy use in the lining of blood vessels and the hormone leptin affect blood vessel health in people with Type 1 diabetes.

More Diabetes research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionAugusta University
NIH-funded
Lab location1 site (Augusta, United States)
Project startJune 5, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$505,582
NIH project number5P01HL160557-03
Project IDNIH-11337458 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with Type 1 diabetes, particularly those experiencing or at risk for vascular dysfunction, could benefit from advances arising from this research.

Less likely to help

People without Type 1 diabetes or without vascular complications may not directly benefit from this specific project.

What this research studies

The project looks at how endothelial cells manage their energy, especially glycolysis, and how this impacts vascular redox balance and vessel relaxation in Type 1 diabetes. It explores why endothelial dysfunction occurs and how female sex and leptin signaling might influence these processes. The research uses molecular and cellular methods to identify key regulators like PFKFB3 and Nox1 and tests whether inhibiting them improves blood vessel function in T1D models. The findings could reveal new targets to prevent vascular complications in people with Type 1 diabetes, especially women who may experience different risks. This work aims to translate basic biology into strategies that protect the blood vessels of patients with T1D.

Why it matters

Potential benefit: Better understanding of the vascular problems in Type 1 diabetes could lead to targeted therapies that improve blood vessel health and reduce cardiovascular complications.

How similar studies have gone: Preliminary data suggest endothelial glycolysis influences vascular function, and inhibiting key enzymes has shown promise in restoring relaxation in T1D models, supporting translation to patients.

Where this research is happening

  • Augusta University
    Augusta, United States
    Active

Researchers

  • Principal investigator: Belin de Chantemele, Eric J — Augusta University
  • Study coordinator: Belin de Chantemele, Eric J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.